Is Ozempic® used for weight loss?

Ozempic® is FDA-approved for type 2 diabetes, not for weight loss. It contains semaglutide, the same molecule as Wegovy®, which is approved for weight management. Your provider will explain which applies to your case.

Do I need to have diabetes to be prescribed it?

Any prescription depends on the judgment of the licensed provider who reviews your history during the evaluation.

How is it different from Wegovy®?

Both contain semaglutide and are made by Novo Nordisk. They differ in their approved indication and available doses: Ozempic® for type 2 diabetes, Wegovy® for weight management.

Treatment

Ozempic^® Injection

Brand-name semaglutide, FDA-approved for type 2 diabetes.

$1,398/mo

Start your evaluation

How this treatment works

Ozempic^® is brand-name semaglutide made by Novo Nordisk and FDA-approved to improve blood sugar control in adults with type 2 diabetes. It acts on the GLP-1 receptor and is given once a week by injection. It may reduce appetite, but it is not specifically approved for weight loss.

What's included

Medical evaluation with a US-licensed provider
A treatment plan personalized to your health history
Medication shipped to your home in discreet packaging
Syringes, needles, and an injection kit
Medical follow-up throughout the program
The full PesoBUENO^™ program, at no additional cost

Side effects and considerations

Nausea, especially when starting or increasing the dose
Constipation or diarrhea
Headache or mild fatigue
Occasional stomach discomfort

This list is not exhaustive. Your doctor will review your full medical history during the evaluation.

Questions about this treatment

Treatment subject to medical review. Available only for adults 18+ in states where telehealth is permitted for this medication.

SaludBUENO guarantee
Free, fast shipping
Doctor-led plans & follow-up
No hidden fees

hola@saludbueno.com 877.283.6624 - 877.BUENO24 5224 W. State Road 46, PMB #358, Sanford, FL 32771

The evaluation available on the SaludBUENO website does not by itself establish a provider-patient relationship between the person completing it and SaludBUENO. CareValidate, a network of U.S.-licensed providers that follows protocols designed for patient safety, sets exclusionary criteria to determine whether a person does not qualify for GLPs treatments. The answers you submit determine whether your case is eligible for review. If you qualify, a licensed provider will review your case before any prescription.

All claims and benefits described on this site are based on experiences reported by patients enrolled in programs that include compounded medications and consultations with health professionals. Results may vary and depend on multiple factors, including program adherence and the treating provider's recommendations.

Compounded GLP medications are produced in FDA-regulated 503A pharmacies. Although these facilities are highly regulated, compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded medications is based on the licensed provider's clinical judgment, taking into account the telehealth consultation and the patient's medical history.

We encourage anyone interested in compounded medications to consult with a health professional about the specific risks and benefits. SaludBUENO does not produce compounded medications. The product received may look different from the images shown on this site.